The rapid development of fluoroquinolone resistance in M. tuberculosis.
Ginsburg
Amy Sarah
AS
Woolwine
Samuel C
SC
Hooper
Nancy
N
Benjamin
William H
WH
Bishai
William R
WR
Dorman
Susan E
SE
Sterling
Timothy R
TR
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D015242:Ofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D011472:Prostatitis / Q000188:drug therapy / Q000382:microbiology; D014376:Tuberculosis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D002939:Ciprofloxacin; D015242:Ofloxacin